As GLP-1 weight-loss drugs like Ozempic reshape how consumers eat, food and beverage manufacturers are racing to develop precision nutrition solutions – using AI and functional ingredients to personalise diets and target metabolism more effectively.
The weight-loss revolution sparked by GLP-1 drugs like Ozempic and Mounjaro is doing more than changing waistlines – it’s transforming the food industry’s relationship with biology.
Precision nutrition is about aligning what we eat with who we are – biologically, metabolically and behaviourally.
As millions of consumers re-evaluate what, when and how they eat, a parallel movement is gaining momentum: precision nutrition.
Author's summary: GLP-1 drugs drive precision nutrition.